FBC-Funded Research
First Gene Therapy Results for Choroideremia Suggest Cautious Optimism
The first human trial of a gene therapy for choroideremia has announced preliminary results on six people: two of these patients have experienced significant improvements in vision. The findings were published in…
Read More
The Genetics of Choroideremia
Dr. Ian MacDonald and his team at the University of Alberta are internationally recognized experts in the study of choroideremia, a rare blinding disease that typically affects young men beginning in adolescence….
Read MoreJoin the Fight!
Learn how your support is helping to bring a future without blindness into focus! Be the first to learn about the latest breakthroughs in vision research and events in your community by subscribing to our e-newsletter that lands in inboxes the beginning of each month.